FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896416611> ?p ?o ?g. }

• W2896416611 endingPage "4240" @default.
• W2896416611 startingPage "4231" @default.
• W2896416611 abstract "Background The impact of National Comprehensive Cancer Network (NCCN) treatment guideline concordance on costs, health care utilization, and mortality for patients with breast cancer and secondary metastases is unknown. Methods From 2007 to 2013, women with early‐stage breast cancer who received treatment for secondary metastases (n = 5651) were evaluated for first recorded systemic therapy concordance with NCCN guidelines within the Surveillance, Epidemiology, and End Results Program–Medicare linked database. Generalized linear and mixed effects models evaluated factors associated with nonconcordance and the relation between concordance status and health care utilization and costs. Mortality risk was estimated with Cox regression. Results Eighteen percent of the patients received nonconcordant therapy, with the most common being single‐agent, human epidermal growth factor receptor 2 (HER2)–targeted therapy (36%), therapy mismatched with the estrogen receptor/HER2 status (11%), unapproved bevacizumab regimens (10%), and adjuvant regimens in a metastatic setting (6%). A younger age, a hormone receptor–negative status, and a HER2‐positive status were associated with nonconcordance ( P < .05). Nonconcordance was associated with 22% and 21% increased rates of emergency department visits and hospitalizations, respectively, and $1765 higher average monthly Medicare costs. Differences in adjusted mortality risk were noted by the category of nonconcordance; single‐agent, HER2‐targeted therapy was associated with decreased mortality risk (hazard ratio [HR], 0.66; 95% confidence limit [CL], 0.57‐0.76), and increased mortality risk was observed with unapproved bevacizumab use (HR, 1.40; 95% CL, 1.13‐1.74). Conclusions Most patients (82%) received treatment consistent with NCCN guidelines. Nonconcordant treatment was associated with higher health care utilization and costs, with mortality differences observed by the type of guideline deviation. Consideration of both patient and financial outcomes will be important as health systems increase the emphasis on guideline‐based care." @default.
• W2896416611 created "2018-10-26" @default.
• W2896416611 creator A5016535621 @default.
• W2896416611 creator A5026681970 @default.
• W2896416611 creator A5030684939 @default.
• W2896416611 creator A5034413439 @default.
• W2896416611 creator A5037680716 @default.
• W2896416611 creator A5040465983 @default.
• W2896416611 creator A5043738456 @default.
• W2896416611 creator A5046549002 @default.
• W2896416611 creator A5046875409 @default.
• W2896416611 creator A5074244901 @default.
• W2896416611 date "2018-10-14" @default.
• W2896416611 modified "2023-09-25" @default.
• W2896416611 title "Concordance with NCCN treatment guidelines: Relations with health care utilization, cost, and mortality in breast cancer patients with secondary metastasis" @default.
• W2896416611 cites W1903117021 @default.
• W2896416611 cites W1985213644 @default.
• W2896416611 cites W2000445173 @default.
• W2896416611 cites W2009268313 @default.
• W2896416611 cites W2015198403 @default.
• W2896416611 cites W2022684250 @default.
• W2896416611 cites W2070335513 @default.
• W2896416611 cites W2091067403 @default.
• W2896416611 cites W2111507522 @default.
• W2896416611 cites W2112800880 @default.
• W2896416611 cites W2113361623 @default.
• W2896416611 cites W2118167058 @default.
• W2896416611 cites W2126275851 @default.
• W2896416611 cites W2129168200 @default.
• W2896416611 cites W2130771089 @default.
• W2896416611 cites W2136166098 @default.
• W2896416611 cites W2137721949 @default.
• W2896416611 cites W2138679191 @default.
• W2896416611 cites W2156864608 @default.
• W2896416611 cites W2157358083 @default.
• W2896416611 cites W2159967578 @default.
• W2896416611 cites W2171244965 @default.
• W2896416611 cites W2173398341 @default.
• W2896416611 cites W2227968747 @default.
• W2896416611 cites W2235394802 @default.
• W2896416611 cites W2271267581 @default.
• W2896416611 cites W2588327302 @default.
• W2896416611 cites W2594246457 @default.
• W2896416611 cites W4230263812 @default.
• W2896416611 doi "https://doi.org/10.1002/cncr.31694" @default.
• W2896416611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30317547" @default.
• W2896416611 hasPublicationYear "2018" @default.
• W2896416611 type Work @default.
• W2896416611 sameAs 2896416611 @default.
• W2896416611 citedByCount "23" @default.
• W2896416611 countsByYear W28964166112019 @default.
• W2896416611 countsByYear W28964166112020 @default.
• W2896416611 countsByYear W28964166112021 @default.
• W2896416611 countsByYear W28964166112022 @default.
• W2896416611 countsByYear W28964166112023 @default.
• W2896416611 crossrefType "journal-article" @default.
• W2896416611 hasAuthorship W2896416611A5016535621 @default.
• W2896416611 hasAuthorship W2896416611A5026681970 @default.
• W2896416611 hasAuthorship W2896416611A5030684939 @default.
• W2896416611 hasAuthorship W2896416611A5034413439 @default.
• W2896416611 hasAuthorship W2896416611A5037680716 @default.
• W2896416611 hasAuthorship W2896416611A5040465983 @default.
• W2896416611 hasAuthorship W2896416611A5043738456 @default.
• W2896416611 hasAuthorship W2896416611A5046549002 @default.
• W2896416611 hasAuthorship W2896416611A5046875409 @default.
• W2896416611 hasAuthorship W2896416611A5074244901 @default.
• W2896416611 hasBestOaLocation W28964166111 @default.
• W2896416611 hasConcept C121608353 @default.
• W2896416611 hasConcept C126322002 @default.
• W2896416611 hasConcept C142724271 @default.
• W2896416611 hasConcept C143998085 @default.
• W2896416611 hasConcept C160798450 @default.
• W2896416611 hasConcept C207103383 @default.
• W2896416611 hasConcept C2776694085 @default.
• W2896416611 hasConcept C2777802072 @default.
• W2896416611 hasConcept C2780182762 @default.
• W2896416611 hasConcept C44249647 @default.
• W2896416611 hasConcept C50382708 @default.
• W2896416611 hasConcept C530470458 @default.
• W2896416611 hasConcept C71924100 @default.
• W2896416611 hasConceptScore W2896416611C121608353 @default.
• W2896416611 hasConceptScore W2896416611C126322002 @default.
• W2896416611 hasConceptScore W2896416611C142724271 @default.
• W2896416611 hasConceptScore W2896416611C143998085 @default.
• W2896416611 hasConceptScore W2896416611C160798450 @default.
• W2896416611 hasConceptScore W2896416611C207103383 @default.
• W2896416611 hasConceptScore W2896416611C2776694085 @default.
• W2896416611 hasConceptScore W2896416611C2777802072 @default.
• W2896416611 hasConceptScore W2896416611C2780182762 @default.
• W2896416611 hasConceptScore W2896416611C44249647 @default.
• W2896416611 hasConceptScore W2896416611C50382708 @default.
• W2896416611 hasConceptScore W2896416611C530470458 @default.
• W2896416611 hasConceptScore W2896416611C71924100 @default.
• W2896416611 hasIssue "21" @default.
• W2896416611 hasLocation W28964166111 @default.
• W2896416611 hasLocation W28964166112 @default.
• W2896416611 hasOpenAccess W2896416611 @default.
• W2896416611 hasPrimaryLocation W28964166111 @default.

• next